The effective radiation dose to immune cells predicts lymphopenia and inferior cancer control in locally advanced NSCLC-Reference-Cited by-同舟云学术

The effective radiation dose to immune cells predicts lymphopenia and inferior cancer control in locally advanced NSCLC

Published:2024-01 Issue: Volume:190 Page:110030
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Friedes Cole^ORCID,Iocolano Michelle,Lee Sang Ho,Duan Lian^ORCID,Li Bolin,Doucette Abigail^ORCID,Cohen Roger B.,Aggarwal Charu,Sun Lova L.^ORCID,Levin William P.,Cengel Keith A.,Kao Gary,Teo Boon-Keng Kevin,Langer Corey J.^ORCID,Xiao Ying,Bradley Jeffrey^ORCID,Feigenberg Steven J.^ORCID,Yegya-Raman Nikhil^ORCID

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference38 articles.

1. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study

2. Long-term results of NRG oncology RTOG 0617: standard- versus high-dose chemoradiotherapy with or without cetuximab for unresectable stage III non–small-cell lung cancer;Bradley;JCO,2020

3. Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC;Antonia;N Engl J Med,2018

4. Five-Year survival outcomes from the PACIFIC trial: durvalumab after chemoradiotherapy in stage III non–small-cell lung cancer;Spigel;JCO,2022

5. Harnessing the immune system for the treatment of non-small-cell lung cancer;Brahmer;J Clin Oncol,2013

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proton Therapy Reduces the Effective Dose to Immune Cells in Mediastinal Hodgkin Lymphoma Patients;International Journal of Particle Therapy;2024-09

2. Proton therapy reduces the effective dose to immune cells in breast cancer patients;Strahlentherapie und Onkologie;2024-07-25

3. Determinants of radiation dose to immune cells during breast radiotherapy;Strahlentherapie und Onkologie;2024-05-27

4. Kaplan lecture 2023: lymphopenia in particle therapy;International Journal of Radiation Biology;2024-03-05

5. Acute hospitalizations after proton therapy versus intensity‐modulated radiotherapy for locally advanced non–small cell lung cancer in the durvalumab era;Cancer;2024-01-31